640 related articles for article (PubMed ID: 30415448)
1. Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson's disease: a detailed PET analysis of 12 striatal subregions.
Park SB; Kwon KY; Lee JY; Im K; Sunwoo JS; Lee KB; Roh H; Ahn MY; Park S; Kim SJ; Oh JS; Kim JS
Neurol Sci; 2019 Feb; 40(2):311-317. PubMed ID: 30415448
[TBL] [Abstract][Full Text] [Related]
2. Cognitive performance correlates with the degree of dopaminergic degeneration in the associative part of the striatum in non-demented Parkinson's patients.
Kübler D; Schroll H; Buchert R; Kühn AA
J Neural Transm (Vienna); 2017 Sep; 124(9):1073-1081. PubMed ID: 28643101
[TBL] [Abstract][Full Text] [Related]
3. An FP-CIT PET comparison of the difference in dopaminergic neuronal loss in subtypes of early Parkinson's disease.
Song IU; Chung YA; Oh JK; Chung SW
Acta Radiol; 2014 Apr; 55(3):366-71. PubMed ID: 23943629
[TBL] [Abstract][Full Text] [Related]
4. Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients.
Erro R; Pappatà S; Amboni M; Vicidomini C; Longo K; Santangelo G; Picillo M; Vitale C; Moccia M; Giordano F; Brunetti A; Pellecchia MT; Salvatore M; Barone P
Parkinsonism Relat Disord; 2012 Nov; 18(9):1034-8. PubMed ID: 22789824
[TBL] [Abstract][Full Text] [Related]
5. Precise Evaluation of Striatal Oxidative Stress Corrected for Severity of Dopaminergic Neuronal Degeneration in Patients with Parkinson's Disease: A Study with 62Cu-ATSM PET and 123I-FP-CIT SPECT.
Neishi H; Ikawa M; Okazawa H; Tsujikawa T; Arishima H; Kikuta KI; Yoneda M
Eur Neurol; 2017; 78(3-4):161-168. PubMed ID: 28848099
[TBL] [Abstract][Full Text] [Related]
6. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
[TBL] [Abstract][Full Text] [Related]
7. Patterns of striatal dopamine depletion and motor deficits in de novo Parkinson's disease.
Jeong SH; Park CW; Lee HS; Kim YJ; Yun M; Lee PH; Sohn YH; Chung SJ
J Neural Transm (Vienna); 2023 Jan; 130(1):19-28. PubMed ID: 36462096
[TBL] [Abstract][Full Text] [Related]
8. Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients.
Santangelo G; Vitale C; Picillo M; Cuoco S; Moccia M; Pezzella D; Erro R; Longo K; Vicidomini C; Pellecchia MT; Amboni M; Brunetti A; Salvatore M; Barone P; Pappatà S
Parkinsonism Relat Disord; 2015 May; 21(5):489-93. PubMed ID: 25753457
[TBL] [Abstract][Full Text] [Related]
9. Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus.
Vriend C; Raijmakers P; Veltman DJ; van Dijk KD; van der Werf YD; Foncke EM; Smit JH; Berendse HW; van den Heuvel OA
J Neurol Neurosurg Psychiatry; 2014 Feb; 85(2):159-64. PubMed ID: 23813742
[TBL] [Abstract][Full Text] [Related]
10. 18F-FP-CIT PET imaging and SPM analysis of dopamine transporters in Parkinson's disease in various Hoehn & Yahr stages.
Wang J; Zuo CT; Jiang YP; Guan YH; Chen ZP; Xiang JD; Yang LQ; Ding ZT; Wu JJ; Su HL
J Neurol; 2007 Feb; 254(2):185-90. PubMed ID: 17334953
[TBL] [Abstract][Full Text] [Related]
11. Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study.
Pellecchia MT; Picillo M; Santangelo G; Longo K; Moccia M; Erro R; Amboni M; Vitale C; Vicidomini C; Salvatore M; Barone P; Pappatà S
Acta Neurol Scand; 2015 May; 131(5):275-81. PubMed ID: 25644029
[TBL] [Abstract][Full Text] [Related]
12. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.
Oh M; Kim JS; Kim JY; Shin KH; Park SH; Kim HO; Moon DH; Oh SJ; Chung SJ; Lee CS
J Nucl Med; 2012 Mar; 53(3):399-406. PubMed ID: 22323779
[TBL] [Abstract][Full Text] [Related]
13. Gray matter correlates of dopaminergic degeneration in Parkinson's disease: A hybrid PET/MR study using (18) F-FP-CIT.
Choi H; Cheon GJ; Kim HJ; Choi SH; Kim YI; Kang KW; Chung JK; Kim EE; Lee DS
Hum Brain Mapp; 2016 May; 37(5):1710-21. PubMed ID: 26846350
[TBL] [Abstract][Full Text] [Related]
14. Striatal dopamine transporter imaging correlates with depressive symptoms and tower of London task performance in Parkinson's disease.
Rektorova I; Srovnalova H; Kubikova R; Prasek J
Mov Disord; 2008 Aug; 23(11):1580-7. PubMed ID: 18618663
[TBL] [Abstract][Full Text] [Related]
15. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
Parkinson Study Group
JAMA; 2000 Oct; 284(15):1931-8. PubMed ID: 11035889
[TBL] [Abstract][Full Text] [Related]
16. Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report.
Di Giuda D; Calcagni ML; Totaro M; Cocciolillo F; Piano C; Soleti F; Fasano A; Cioni B; Bentivoglio AR; Giordano A
Nucl Med Commun; 2012 Sep; 33(9):933-40. PubMed ID: 22735298
[TBL] [Abstract][Full Text] [Related]
17. Rapid eye movement sleep behaviour disorder and striatal dopamine depletion in patients with Parkinson's disease.
Chung SJ; Lee Y; Lee JJ; Lee PH; Sohn YH
Eur J Neurol; 2017 Oct; 24(10):1314-1319. PubMed ID: 28782870
[TBL] [Abstract][Full Text] [Related]
18. Apathy and striatal dopamine defects in non-demented patients with Parkinson's disease.
Chung SJ; Lee JJ; Ham JH; Lee PH; Sohn YH
Parkinsonism Relat Disord; 2016 Feb; 23():62-5. PubMed ID: 26717857
[TBL] [Abstract][Full Text] [Related]
19. Striatal dopamine loss and discriminative sensory dysfunction in Parkinson's disease.
Lyoo CH; Ryu YH; Lee MJ; Lee MS
Acta Neurol Scand; 2012 Nov; 126(5):344-9. PubMed ID: 22380639
[TBL] [Abstract][Full Text] [Related]
20. Smoking in Patients with Parkinson's Disease: preliminary striatal DaT-SPECT findings.
Gigante AF; Defazio G; Niccoli Asabella A; Superbo M; Ferrari C; Liuzzi D; Iliceto G; Livrea P; Rubini G
Acta Neurol Scand; 2016 Oct; 134(4):265-70. PubMed ID: 26659996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
